176 related articles for article (PubMed ID: 12506470)
1. [Progress in postoperative adjuvant chemotherapy in gastric cancer].
Nakajima T; Ohta K; Ohyama S; Yamaguchi T
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2481-7. PubMed ID: 12506470
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of clinical trials on adjuvant chemotherapy for curatively resected gastric cancer].
Kitamura M; Arai K; Iwasaki Y
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1221-9. PubMed ID: 9279340
[TBL] [Abstract][Full Text] [Related]
4. [Overview of clinical trials on adjuvant chemotherapy for curatively resected gastric cancer].
Sasako M; Sano T; Katai H; Okajima K; Maruyama K
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():384-94. PubMed ID: 7986119
[TBL] [Abstract][Full Text] [Related]
5. [Current status and problem of adjuvant chemotherapy for curatively resected gastric cancer].
Saka M; Sasako M; Katai H; Sano T
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2033-42. PubMed ID: 11103234
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives.
Sakamoto J; Morita S; Kodera Y; Rahman M; Nakao A
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S25-31. PubMed ID: 15309511
[TBL] [Abstract][Full Text] [Related]
7. [Meta-analysis of 10 postoperative adjuvant chemotherapies for gastric cancer in CIH].
Nakajima T; Ota K; Ishihara S; Oyama S; Nishi M; Hamashima N
Gan To Kagaku Ryoho; 1994 Aug; 21(11):1800-5. PubMed ID: 8080299
[TBL] [Abstract][Full Text] [Related]
8. [Comparative clinical study of adjuvant postoperative chemotherapy (5-FU, Tegafur, 5-FU + MMC) in curatively resected cases of gastric cancer. Study Group on 5-FU Oral Adjuvant Chemotherapy in Gastric Cancer].
Nakajima T; Miwa K; Ohmori Y; Sakabe T; Fujii M; Kajitani T
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1161-8. PubMed ID: 8751804
[TBL] [Abstract][Full Text] [Related]
9. [Conditions suitable for the adjuvant chemotherapy of gastric cancer].
Nakajima T; Takahashi T; Takagi K; Kuno K; Kajitani T
Gan No Rinsho; 1983 Aug; 29(10):1229-36. PubMed ID: 6415314
[TBL] [Abstract][Full Text] [Related]
10. [Progress in adjuvant therapy for colorectal cancer].
Kohnoe S; Kakeji Y; Maehara Y
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2488-97. PubMed ID: 12506471
[TBL] [Abstract][Full Text] [Related]
11. [Comparison the standard therapies of gastric cancer in Japan with those in the West].
Sasaki E; Maeda Y; Sasaki T
Gan To Kagaku Ryoho; 2007 May; 34(5):700-4. PubMed ID: 17496440
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
Budach W; Hehr T; Budach V; Belka C; Dietz K
BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
[TBL] [Abstract][Full Text] [Related]
14. Overview of adjuvant therapy for resected gastric cancer: differences in Japan and the United States.
Ohtsu A; Sasako M
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S101-4. PubMed ID: 16399444
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy for gastric cancer in Japan: present status and suggestions for rational clinical trials.
Nakajima T
Jpn J Clin Oncol; 1990 Mar; 20(1):30-42. PubMed ID: 2181170
[TBL] [Abstract][Full Text] [Related]
16. 5-fluorouracil, mitomycin-C, and polysaccharide-K adjuvant chemoimmunotherapy for locally advanced gastric cancer: the prognostic significance of frequent perineural invasion.
Choi JH; Kim YB; Lim HY; Park JS; Kim HC; Cho YK; Han SW; Kim MW; Joo HJ
Hepatogastroenterology; 2007; 54(73):290-7. PubMed ID: 17419278
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of FEM (5-fluorouracil, epirubicin, mitomycin C) therapy for resected advanced gastric cancer. Ehime Gastric Cancer Study Meeting].
Kurita A; Takashima S; Sakakihara Y; Tsunekawa K; Matsuzaka T
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2319-24. PubMed ID: 8259845
[TBL] [Abstract][Full Text] [Related]
18. [Adjuvant chemotherapy for advanced gastric cancer].
Furukawa H; Hiratsuka M; Iwanaga T; Imaoka S; Ishikawa O; Kabuto T; Sasaki Y; Kameyama M; Ohigashi H; Nakamori S; Nakano H; Yasuda T
Nihon Geka Gakkai Zasshi; 1996 Apr; 97(4):312-6. PubMed ID: 8692150
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy for colorectal carcinoma.
Kim R; Yamaguchi Y; Toge T
Anticancer Res; 2002; 22(4):2413-8. PubMed ID: 12174936
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer.
Sun P; Xiang JB; Chen ZY
Br J Surg; 2009 Jan; 96(1):26-33. PubMed ID: 19016271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
